Riskpilot← Back to searchSign inGet full accessAB Blomgård Hälsa
ABActiveOrg 5567788988Fjelievägen 15 BOther human health activities n.e.c. · NACE 8699Est. 20092 employees
Revenue 2025
SEK 2,9M
+11% vs 2024
EBITDA margin
13.5%
-39% vs 2024
Equity ratio
53.9%
Financial strength
Net profit 2025
SEK 299K
-40% vs 2024
| Revenue | SEK 2,9M | +11% |
| EBITDA | SEK 386K | -39% |
| Net profit | SEK 299K | -40% |
| Total assets | SEK 1,1M | -4% |
| Equity | SEK 586K | -15% |
| Employees | 2 | — |
Legal name
AB Blomgård Hälsa
Org number
5567788988
Legal form
Aktiebolag
NACE code
8699 · Other human health activities n.e.c.
Founded
4 mars 2009
Share capital
SEK 100 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva öppen hälso- och sjukvård, medicinsk och psykosocial rådgivning. Handel med värdepapper. Konsultation inom företagshälsovård, friskvård, idrottsmedicin samt handel med utrustning till nämnda verksamheten.
Address
Fjelievägen 15 B
Email
mikael.blomgard@comhem.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 130 | 2 323 | 2 520 | 2 584 | 2 865 |
| Staff expenses | — | — | — | −1 479 | −1 753 |
| EBITDA | 557 | 612 | 415 | 638 | 386 |
| Depreciation & amort. | −13 | −13 | −6 | −6 | −6 |
| EBIT | 544 | 599 | 409 | 632 | 380 |
| Net financials | −1 | −2 | −1 | 0 | −1 |
| Profit before tax | 542 | 598 | 408 | 632 | 379 |
| Tax | −113 | −125 | −91 | −133 | −80 |
| Net profit | 429 | 473 | 317 | 499 | 299 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 052 | 983 | 996 | 1 136 | 1 087 |
| Equity | 578 | 661 | 578 | 687 | 586 |
| Long-term debt | 150 | 0 | 0 | 150 | 150 |
| Short-term debt | 324 | 322 | 418 | 299 | 351 |
| Total debt | 474 | 322 | 418 | 449 | 501 |
EBITDA margin
13.5%
This company
15.8%
Market median
-15% vs market
20212025
Equity ratio
53.9%
This company
38.2%
Market median
+41% vs market
20212025
Return on equity
51.1%
This company
18.4%
Market median
+178% vs market
20212025
Net profit margin
10.4%
This company
8.1%
Market median
+28% vs market
20212025
Asset turnover
2.64×
This company
1.12×
Market median
+136% vs market
20212025
Debt / equity
0.86×
This company
0.62×
Market median
+39% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AB Blomgård Hälsa also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Inez Margaretha Blomgård | Deputy Board Member | 0 companies |
| Dag Mikael Blomgård | Board of Directors | 0 companies |